The shift from fee-for-service to value-based care is transforming the role of clinical laboratories. Instead of being transactional providers of test results, the most forward-looking aim for laboratorians is to serve as strategic drivers of patient and population health. This idea is at the core of the Clinical Lab 2.0 movement , , which emphasizes how structured, longitudinal laboratory data can be transformed into insights that drive early detection, preventive interventions, and optimized outcomes.

In this framework, the laboratory is no longer only a responder to physician orders. Rather, it becomes an active contributor to the patient care pathway by stratifying risk and identifying patients at elevated risk, surfacing missed tests or incomplete workups to close gaps in care, ensuring timely follow-up and evidence-based management to facilitate interventions, ultimately reducing both disease burden and healthcare costs through improved outcomes.

Inspired by this concept, we conducted a study to evaluate how a proactive laboratory-assisted platform can close diagnostic gaps and ensure alignment with clinical guidelines.